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Abstract
Background: Several studies have shown that the pathophysiology of homozygous sickle cell anaemia (SCA)
results in a myriad of metabolic, nutritional, haematological and clinical effects that interact with other co-morbid
factors to determine the quality of life and life expectancy of afflicted patients. Because of its critical roles in
nutrition and metabolism, inflammation, haematopoiesis and cellular immunity, this study determined the plasma
levels of leptin in steady and unsteady states of HbSS in Nigerian patients.
Methods: A total of 51 SCA patients aged 5 - 35 years with 34 (61.8%) being females who were either on
admission or visiting four medical centres in Lagos, Nigeria together with 22 non-SCD controls aged 5 -30 years
comprising 12 (54.5%) females were enrolled after obtaining their informed consent and ethical approval. Patients
were further stratified into steady and unsteady cases of SCA based on clinical presentations, while blood samples
collected by venipuncture from each of the study participants were analyzed haematologically for full blood count
and HbF level and microscopically for malaria, while plasma leptin was assayed using ELISA method. Body
composition defined by weight, fat mass and body mass index (BMI) was determined using standard methods.
Data obtained for cases and controls were analyzed statistically.
Results: Twenty - one patients had unsteady HbSS and elicited greater and significant (P < 0.05) reduction in fat
mass, BMI, HbF and eosinophil count but elevated mean total leukocyte, count, level of irreversibly sickled cells and
P. falciparum parasitaemia (4613.7 vs. 749.6 - 1078.4 parasites/uL), pyrexia rate (58.3 vs. 25.8%) when compared with
steady state patients or non-SCD controls. Compared to the control, significant decreases in plasma leptin before
and after controlling for body fat that was worsened by crisis were observed among the SCD patients. Unlike the
non-SCD controls, leptin correlated non-significantly (P > 0.05) with all body composition indices measured in the
patients except for fat mass in unsteady cases. Multivariate regression analysis identified ESR and RC as
independent predictor of low plasma leptin concentration in the SCA patients.
Conclusions: Base on these findings, we conclude that plasma level of leptin is further decreased in the unsteady
state of HbSS, shows poor correlation with adiposity and malarial infection but has inflammation and poor
reticulocyte response as independent predictors among Nigerian patients.
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Background
Homozygous sickle cell anaemia (SCA) also called
HbSS, is a form of sickle cell disease that results from
single amino acid substitution (Val for Glu) at the sixth
position in each of the two beta globin chain of haemo-
globin (a2b
s
2) and has remained a non-infectious disease
of high morbidity and mortality world wide particularly
in black populations, Asia and Mediterranean countries
[1].
N i g e r i ah a st h eh i g h e s tb u r d e no fH b S Si nt h ew o r l d
with ~2% of the population affected by the disease [2].
HbSS produces a myriad of metabolic, haematological,
nutritional and clinical effects. Studies have shown that
HbSS is associated with decreased food intake, weight
gain and delayed puberty especially in females [3]. * Correspondence: bamwal@yahoo.com
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stable but endothelial activation and subclinical vaso-
occlusions due to inherent microvascular abnormalities
are an ongoing process coupled with chronic but slow
red cell haemolysis, platelet activation and moderate
cytokine and acute phase response [4]. These pathophy-
siological events are generally insufficient to induce
painful crisis [4,5].
However, in the unsteady state of sickle cell anaemia
(SCA), these pathognomic events are exaggerated and
the consequence is severe vaso-occlusion and blood flow
that leads to organ damage and painful crisis with com-
plications such as bone and joint infarction, acute chest
syndrome, severe anaemia, aplastic anaemia and acute
renal failure [6]. These complications have well been
reported as the causes of hospitalization and deaths in
afflicted patients in Nigeria and other countries [7,8].
It has been reported that more than 50% of patients with
m o s ts e v e r ef o r mo fH b S Sd i eb e f o r et h ea g eo f5y e a r s
[8,9]. Studies have also shown that HbSS patients are
highly susceptible to infections due to abnormality of their
innate immune response including a defective alternate
complement system and Plasmodium falciparum parasi-
taemia has been reported by many investigators as a
pathognomic factor of painful crisis in patients residing in
malaria endemic countries [10,11].
In the past 10 years and with the advent of new technol-
ogies and discoveries, there has been an increased interest
on ways to increase understanding of pathophysiology of
HbSS with regards to the roles played by the regulated
inflammatory mediators (e.g. a2 macroglobulin), endothe-
lial stress factors (e.g. soluble thrombomodulin) and plate-
let factors (e.g. beta TG) in the steady state and how these
factors can be modified to improve the quality of life and
avert painful crisis in patients [12-14].
Leptin, a 16 kDa peptide hormone, derived mainly from
the adipose tissue is a prominent biological factor of
energy homeostasis whose circulating levels are a reflec-
tion of adiposity in human and animals [15]. The hormone
binds to the hypothalamus through the leptin receptor and
acts via the JAK/STAT pathway to inhibit the expression
norexigenic factors but activate the expression of anorexi-
genic factors to suppress appetite, food intake and weight
gain [16]. Therapeutically, leptin has been found to be
beneficial in the management of obesity and lipoatrophy
in HIV patients [17], while in wasting and decreased
energy intake disease conditions such as cancer, tuberculo-
sis, and hepatitis A, B and C infections, decreased serum
levels of leptin were found in consonance with decreased
cellular immunity [18-21]. In mice, starvation has been
used to reduced serum leptin level and evoke an increased
susceptibility to endotoxic shock, while in humans uptake
of leptin has been associated with an improved T. cell
response and intake of micronutrients [22-24]. Leptin has
also been found to play important roles in haematopoiesis
as it contributes to erythropoiesis and erythropoietin pro-
duction by the kidney [25]. There are also evidence that
leptin potentiates platelet activation [26].
Given the fact that HbSS patients are inadequate in cel-
lular immunity [7-10], hypercatabolic in metabolism [27],
prone to anorexia and growth deficit, elicits higher resting
energy expenditure (28) and experience chronic haemoly-
tic and inflammatory episodes even in the steady state
relative to non-SCD humans [29], there is a need to
understand the possible role of leptin in the pathophysiol-
ogy of HbSS.
The aim of this study was to determine plasma levels of
leptin and investigate its associations with body composi-
tion, malaria, haemolytic, sickling and inflammatory
parameters.
Methods
Study participants
This study analyzed 77 blood samples obtained between
December 2009 and May 2010 from SCA patients (n = 55)
aged 5 - 35 years (mean age = 15.3 ± 1.1 yr) of whom 30
(54.5%) were males and 22 non-SCD control subjects. The
patients were attending sickle cell clinics at Lagos State
University Teaching Hospital (LASUTH), Lagos University
Teaching Hospital (LUTH), Maternal and Child Complex,
General Hospital, Ikorodu, and some district hospitals in
Lagos State, Nigeria. To participate in the study, a written
informed consent from each patient (directly if adult or
through parents/guardian of a child) was obtained. The
study protocol was approved by the Ethical committee of
the Hospital Management board, Lagos State, Nigeria.
SCD-HbSS was ascertained based on a positive sickling
test [30] and cellulose acetate electrophoresis of b
s-haemo-
globin at pH 8.6 compared to the controls: HBAA, HBAS,
HBSS and HBSC [30]. Patients in a steady state were
defined as those without any of the following clinical con-
ditions 4 weeks prior to or at enrollment. They include
painful bone crisis, severe anaemia, laboratory diagnosis of
bacteremia, acute chest syndrome, aplastic anaemia, sple-
nic sequestration and behaviors such as anxiety and hallu-
cination. Patients with any one or a combination of these
clinical and behavioral presentations were said to be in an
unsteady state or crisis [1,6,7,29]
Nutritional Assessment
This was based on the determination of body mass
index (BMI) of each study participant. Here, the patients
and control subjects were weighed barefoot with mini-
mum clothing using a digital scale. The body weight
was recorded to the nearest 0.1 kg. Height was mea-
sured to the nearest 0.1 cm using a ruler tape. BMI was
then calculated as weight (Kg) divided by the square of
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2). Fat mass (FM) defined as total body weight
minus lean mass was determined by calculation [31]
Laboratory analysis
Blood samples were collected from each study participant
by venipuncture into separate and labeled EDTA tubes
for haematological and biochemical assays. The haemato-
logical parameters assayed include packed cell volume
(hematocrit) by the standard heparinized capillary tube
method according to Dacie and Lewis [32]. Whole blood
haemoglobin level was determined using the Drabkin’s
reagent [33] and aliquots of blood sample (20 uL each)
were lysed in volume ratio 1:20 with Turk’ss o l u t i o n( 2 %
glacial acetic acid in water plus gentian violet) and 1%
ammonium oxalatae and in ratio 1: 100 with Tommasson
solution (NaCl, 1 g; Na2SO4, 8 g; glycerol, 20 mL; distilled
water, 160 mL) for the determination of total leukocyte,
platelets and erythrocyte counts. The cells were counted
using an improved Neubauer Hematocytometer at × 40
magnification. Differential leukocyte counts of neutro-
phils, lymphocytes, monocytes, eosinophils and basophils
were done by microscopically examined Leishman’s
stained blood films under oil immersion (× 100 magnifi-
cation) with results expressed as percentages of the total
number of leukocytes enumerated in the high power
fields [34]. Absolute count for each leukocyte was then
calculated by multiplying the differential count result by
the total leukocyte count [29]. Hamatological parameters:
mean corpuscular haemoglobin concentration (MCHC)
in g/dL of packed cell volume and mean corpuscular hae-
moglobin (MCH) in pg per cell were also determined by
calculation [32]. Erythrocyte sedimentation rate (ESR) in
mm/hr was also determined manually using the Western
Green method [32]. Reticulocyte counts were performed
on blood films pre-stained with brilliant cresyl blue
supravital stain for 5 min and expressed as a percentage
of 200 nucleated and non-nucletaed erythrocytes counted
in 4 - 5 fields. Irreversible sickle cells (ISC) were also
examined microscopically (at × 100 magnification) on
another Leishman’s stained blood film and expressed as a
percentage of total number of erythrocytes counted [35].
Thick (~ 12 uL) and thin (3 uL) blood films stained with
4% Giemsa stain for 30 min were also prepared and used
for detection and enumeration of malaria parasites. For
positive cases, parasites were counted against 200 - 500
leukocytes and expressed as parasites per uL of whole
blood by assuming that 1 uL of whole blood contains
8000 leukocytes [36]. A slide was considered to be nega-
tive when no parasites were seen after examination of
100 high power fields [36].
Fasted (~ 10 h) plasma recovered from EDTA blood
samples by centrifugation at 2500 rpm for 5 min was
used for leptin assay. The plasma samples were stored
in separate plain tubes at -20°C prior to biochemical
analysis. Plasma leptin concentrations were measured by
capture ELISA method according to guidelines of
the manufacturer (Quantikine DLP00, R&D Systems,
Minneapolis, MN). The standard leptin solution was
calibrated at 0.5 - 100 ug/L and intra -assay coefficient
variation (CV) for low and high controls were 1.3% and
3.0% respectively.
Statistical analysis
Data expressed as mean ± SD and percentages (%) were
analyzed using SPSS version 7.5.2 for Windows (SPSS,
Inc., Chicago, IL). Patients and controls were compared
regarding their plasma leptin concentrations, body weight,
body mass index (BMI) (calculated as weight/height
2, kg/
m
2) and haematological parameters using Student’s t test
or Mann-Whitney U test as appropriate. Disparity
between percentages was evaluated using Chi-square (c2)
test. The relationship betweenp l a s m al e p t i nc o n c e n t r a -
tions and BMI and between plasma leptin, fat mass (FM)
and each of the haematological parameters measured was
analyzed by univariate regression. Multivariate regression
models were used to determine independent determinants
of plasma leptin levels in SCD-HBSS. Outcomes with
probability (P) value < 0.05 were considered to be
significant.
Results
Table 1 presents demographic and haematological charac-
teristics of the sickle cell anaemia (SCA) patients and the
non-SCD control. Of the 55 patients enrolled, 31 were
steady SCA patients and comprised 16 males and 15
females, while 24 patients were unstable and consisted of
9 males and 15 females. In comparison with the non-SCD
control (n = 24), significant( P< 0 . 0 5 )i n c r e a s e si nt h e
levels of HbF, ESR, reticulocytes, total leukocytes, neutro-
phils, lymphocytes, monocytes, eosinophils and platelet
counts were found in the SCA patients as a whole.
Furthermore, when compared with stable patients, those
in unsteady state were found to elicit further significant
(P < 0.05) elevations of these parameters including the
level of irreversible sickle cells except for HbF and reticu-
locytes count. The prevalence rates of MCH < 25 pg were
found to be 13.6%, 51.6% and 79.2% in the control, steady
and unsteady patients respectively (P < 0.05). The percen-
t a g e so fp a t i e n t sw i t hM C H C<3 1g / d Lw e r e9 . 7 %a n d
29.2% in stable and unstable patients respectively (P <0.05).
In Table 2, parasite rates of 13.6%, 19.4% and 41.7%
and corresponding densities of 1078.4, 749.6 and 4613.7
parasites/uL were found in the non-SCD controls and
SCA patients in steady and unsteady steady are shown.
On the whole, the parasite rate and density of the SCA
patients were significantly (P <0.05) higher than those of
the non-SCD controls. However, the two patient sub-
groups did not differ significantly ((P > 0.05) in their
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level of parasitaemia. The SCA patients were further
found to elicit higher mean axillary temperature (37.4 ±
0.07 vs. 37.1 ± 0.04 °C; P <0.05) when compared with
non-SCD controls and showed greater increase in this
parameter when being in an unsteady state (37.7 ± 0.1
vs. 37.2+0.06 °C). The pyrexia rates in these patients
were 25.8% and 58.3% respectively (P < 0.05) (Table 2).
In comparison by gender, significant (P < 0.05) dispar-
ity was observed between steady SCA and unsteady SCA
patients in the overall mean body weight (26.1 - 31.9 ±
2.9-3.8 vs. 22 - 28.8 ± 2.2 - 2.5 kg) and also specifically
in men (40.5 ± 1.0 vs. 33 ± 0.3 kg), girls (19.3 ± 2.8 vs.
17.8 ± 1.4 kg) and women (43.3 ± 3.4 vs. 35.8 ± 0.3 kg)
(Table 3). Higher levels of fat mass in boys (3.6 ±
0.5 kg) and women (9.6 ± 0.9 vs. 8.3 ± 0.9 kg); leptin in
boys (2.4 ± 0.03 vs. 1.6 ± 0.08 ug/L), girls (4.2 ± 0.2 vs.
2.9 ± 0.1 ug/L) and women (6.9 ± 0.2 vs. 3 ± 0.1 ug/L)
and leptin to fat mass ratio (Leptin/FM) in women (0.72
± 0.05 vs.0.39 ± 0.06 ugL
-1kg
-1)w e r ea l s of o u n di nt h e
steady SCA patients compared to unsteady SCA patients
(Table 3). Except in boys, the observed disparity in BMI
between the two case groups was not significant (P >
0.05) (Table 3)
The results presented in Table 4 showed that these
parameters were significantly (P < 0.05) higher by
Table 1 Demographic and Haematological Characteristics of the Sickle Cell Anaemia Patients
SCA Patients
Parameter Control Total Steady Unsteady
No. of cases 22 55 31 24
Sex, Male/Female 10/12 25/30 16/15 9/15
Age, yr 13.0 ± 1.5 15.3 ± 1.1 17.1 ± 1.6* 13.2 ± 1.1
aHbF, % 1.3 ± 0.06 3.8 ± 0.2** 4.2 ± 0.2* 3.3 ± 0.2
Hb, g/dL 11.9 ± 0.2 8.3 ± 0.2** 8.9 ± 0.2* 7.4 ± 0.3
PCV, % 35.2 ± 0.5 25.5 ± 0.5** 27.3 ± 0.5* 23.2 ± 0.7
RC, % 1.7 ± 0.1 5.8 ± 0.3** 6.3 ± 0.4* 5.3 ± 0.6
% ICI ND 6.7 ± 0.3 5.3 ± 0.3* 8.4 ± 0.4
MCHC, g/dL 34.0 ± 0.5 32.4 ± 0.2** 32.8 ± 0.3* 31.7 ± 0.2
MCH, pg 27.4 ± 0.5 23.9 ± 0.4** 25.0 ± 0.4* 22.6 ± 0.6
MCHC < 31 g/dL, n(%) 0(0) 10 (18.2) 3 (9.7)* 7 (29.2)
MCH < 25 pg, n(%) 3 (13.6) 35 (63.6)** 16 (51.6)* 19 (79.2)
ESR, mm/Hr 14.4 ± 3.5 35.1 ± 1.0** 25.7 ± 1.1* 38.4 ± 1.3
WBC, cells/uL × 10
3 6.1 ± 0.2 11.7 ± 0.1** 11.4 ± 0.2* 12.1 ± 0.1
Neutrophils, cells/uL × 10
3 3.4 ± 0.1 7.6 ± 0.1** 7.2 ± 0.2* 8.1 ± 0.2
Lymphocytes, cells/uL × 10
3 2.0 ± 0.09 2.6 ± 0.1** 2.6 ± 0.1 2.4 ± 0.1
Monocytes, cells/uL × 10
3 0.5 ± 0.04 1.0 ± 0.06** 0.9 ± 0.08 1.2 ± 0.09
Eosinophils, cells/uL × 10
3 0.2 ± 0.02 0.4 ± 0.03** 0.5 ± 0.04* 0.3 ± 0.04
Basophils, cells/uL × 10
3 0.08 ± 0.01 0.2 ± 0.02 0.1 ± 0.02 0.2 ± 0.04
Platelet count, cells/uL × 10
3 241.8 ± 11.6 432.8 ± 82.6** 438.7 ± 11.1* 371.5 ± 16.2
RBC count, cells/uL × 10
6 4.4 ± 0.07 3.5 ± 0.05** 3.6 ± 0.04* 3.3 ± 0.07
Data are expressed as mean ± SEM or number (%).
aHbF was evaluated in 10 control subjects. *P < 0.05 (Steady vs. Unsteady SCA patients); **P < 0.05 (Total SCA
patients vs. Control) by Student’s t-test or Chi-Square (c2) analysis; P < 0.05 was considered to be significant.
Table 2 Levels of Plasmodium falciparum parasitaemia among the Sickle Cell Anaemia Patients and non-SCD controls
SCA Patients
Parameter Control Steady Unsteady Total
No. of cases 22 31 24 55
Pf parasitaemia, n (%) 3 (13.6) 6 (19.4) 10 (41.7) 16 (29.1)
Relative risk, RR (95% CI) 0.4 (0.08 - 1.7)^
GMPD, parasites/uL 1078.4 749.6* 4613.7 2335**
Axillary Temperature, (°C)
Range (mean) 36.8 - 37.4 (37.1 ± 0.04) 36.8 - 37.7(37.2 ± 0.06)* 36.7 - 38. 9(37.7 ± 0.1) 36.7 - 38. 9 (37.4 ± 0.07)**
@Pyrexia rate, n (%) 0 6(25.8)* 14 (58.3) 20 (36.4)
Data are expressed as range (mean ± SEM) or number (%); n = Number of positive cases *P < 0.05 (Stable vs. Unstable SCD patients); **P < 0.05 (Total SCD
patients vs. Control) by Student’s t-test or Chi-Square (c2) analysis; ^Relative risk was not significant; P < 0.05 was considered to be significant. GMPD =
Geometric mean parasite density;
@Pyrexia was defined as axillary temperature > 37.4°C
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Page 4 of 11Table 3 Comparative Analysis of Body Composition and Plasma Leptin levels among the Sickle Cell Anaemia Patients in the Steady and Unsteady States
^SCA Patients
Parameter Steady
Males
Boys
Men Total Females
Girls
Women Total Unsteady
Males
Boys
Men Total Females
Girls
Women Total
(n) (6) (10) (16) (9) (6) (15) (7) (2) (9) (10) (5) (15)
Age, yr 8.3 ± 1.4
b 25.7 ± 1.7
a 17.1 ± 1.6
a 8.7 ± 0.8 23.3 ± 2.2 14.5 ± 2.1 10 ± 1.2 17.5 ± 0.5 11.7 ± 1.5 10.9 ± 1.1 20.4 ± 2.2 15.1 ± 1.6
Weight, kg 17.8 ± 1.5
b 40.5 ± 1.0
a 31.9 ± 2.9
a,b 19.3 ± 2.8
a 43.3 ± 3.4
a 26.1 ± 3.8
a 18.8 ± 1.1 33.0 ± 0.2 22.0 ± 2.2 17.8 ± 1.4
c 35.8 ± 1.3 28.8 ± 2.5
BMI, kg/m
2 18.4 ± 0.2
a 19.0 ± 0.3 18.7 ± 0.2 18.9 ± 0.5 19.6 ± 0.8
a 19.2 ± 0.5 19.7 ± 0.1
c 18.4 ± 0.4 19.4 ± 0.5 18.5 ± 0.5 17.9 ± 0.3 18.3 ± 0.4
FM, kg 3.6 ± 0.5
a,,b 8.2 ± 0.4 6.5 ± 0.5 4.6 ± 0.6 9.6 ± 0.9
a 6.0 ± 0.8 4.8 ± 0.5 8.9 ± 0.04 5.7 ± 0.7 4.4 ± 0.4 8.3 ± 0.9 5.7 ± 0.6
Leptin, ug/L 2.4 ± 0.03
a,b 2.1 ± 0.05 2.2 ± 0.04
a,b 4.2 ± 0.2
a 6.9 ± 0.2
a 5.3 ± 0.4
a 1.6 ± 0.08 1.8 ± 0.3 1.6 ± 0.09 2.9 ± 0.1 3.0 ± 0.1 3.0 ± 0.09
Leptin/FM 0.7 ± 0.08
b 0.27 ± 0.01
b 0.43 ± 0.06
b 1.04 ± 0.09
a 0.72 ± 0.06
a 0.98 ± 0.08
a 0.52 ± 0.05 0.2 ± 0.03 0.42 ± 0.05 0.7 ± 0.05
c 0.39 ± 0.06
c 0.6 ± 0.05
c
n = Number of cases, Data are mean ± SEM
aP < 0.05 Significantly different in the same gender by age category (Stable vs. Unstable (Mann-Whitney U test)
bP < 0.05 Significantly different in the between gender by age category in steady HbSS Patients (Mann-Whitney U test)
cP < 0.05 Significantly different in the between gender by age category in unsteady HbSS Patients (Mann-Whitney U test)
^Age was set at ≤ 16 years for boys or girls and > 16 years for men or women
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1Table 4 Comparative Analysis of Body Composition and Plasma Leptin levels between the Sickle Cell Anaemia Patients and Control
^Subjects
SCA Patients Control
Parameter Males
Boys
Men Total Females
Girls
Women Total Males
Boys
Men Total Females
Girls
Women Total
N (17) (8) (25) (16) (14) (30) (7) (3) (10) (7) (5) (12)
Age, yr 8.3 ± 1.4 25.7 ± 1.7 17.1 ± 1.6
a 8.7 ± 0.8 23.3 ± 2.2 14.5 ± 2.1 9 ± 0.8 27.2 ± 0.2 10.8 ± 2.0 9.6 ± 1.2 22 ± 2.7 14.8 ± 2.2
Weight, kg 18.2 ± 0.9 35.9 ± 1.2
a,b 23.9 ± 1.9 17.6 ± 1.6 41.3 ± 1.4 28.7 ± 2.4 18.2 ± 1.7 60.2 ± 1.5 20.8 ± 3.0 21.8 ± 0.8 49 ± 2.6 33 ± 4.4
BMI, kg/mm2 19 ± 0.4 18 ± 0.2
a 18.7 ± 0.3
a 18.7 ± 0.4
a 19.3 ± 0.3
a 19 ± 0.2 20.1 ± 0.4 23 ± 0.6 20.2 ± 0.4 21.8 ± 0.8 20.7 ± 0.7 21.2 ± 0.4
FM, kg 4.6 ± 0.8 8.4 ± 0.5
a 5.8 ± 0.5 4 ± 0.3 8.7 ± 0.5 6.2 ± 0.5 4.6 ± 0.5
c 19.3 ± 0.5
c 5.5 ± 1.0
c 6.5 ± 0.7 14.4 ± 0.8 21.3 ± 0.5
Leptin, ug/L 1.9 ± 0.9
a,b 2.1 ± 0.07 2 ± 0.07
b 3.7 ± 0.3
a 2.1 ± 0.7
a 4.1 ± 0.3
a 2.5 ± 0.05
c 2.4 ± 0.09
c 2.5 ± 0.05
c 10.1 ± 0.6 16.3 ± 1.4 12.7 ± 1.2
Leptin/FM 0.45 ± 0.03
a,b 0.26 ± 0.02
a,b 0.39 ± 0.04
a,b 0.96 ± 0.09
a 0.55 ± 0.06
a 77 ± 0.06
a 0.58 ± 0.05
c 0.12 ± 0.004
c 0.19 ± 0.06
c 1.6 ± 0.1 1.1 ± 0.1 1.4 ± 0.1
Data are mean ± SEM
aP < 0.05 Significantly different in the same gender by age category [SCA Patients vs. Control (Mann-Whitney U test)]
bP < 0.05 Significantly different in the between gender by age category in SCA Patients (Mann-Whitney U test)
cP < 0.05 Significantly different in the between gender by age category in the Control Patients (Mann-Whitney U test)
^Age was set at ≤ 16 years for boy or girls and > 16 years for men or women
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1gender and age in non-SCD controls compared to SCA
patients except weight and BMI. Significant (P < 0.05)
disparity in age and fat mass was only observed in male
SCA patients (17.1 ± 1.6 vs. 10.8 ± 2 yr) and men (8.4 ±
0.5 vs. 19.3 ± 0.5 kg) respectively (Table 4). Of the
anthropometric data correlated with serum leptin level,
only age in unsteady SCA patients showed significant
(P < 0.05) direct relationship. This was contrary to the
significant (P < 0.05) associations between age, body
weight, fat mass and serum leptin level seen in the non-
SCD control (Results not shown).
On the effect of haemolysis, inflammation and sickling
on leptinemia among the SCA patients, we found non-
significant (P > 0.05) association between leptin and hae-
molytic parameters (PCV, MCHC, MCH, RBC) mea-
sured; negative but significant correlation between leptin
and ESR (r = -0.55 to -0.79; P <0.01) and between leptin
and platelet count (r = -0.39; P = 0.03) only in stable
patients. However, serum leptin association with reticulo-
cyte count was positive and significant in stable (r = 0.52;
P = 0.003) and all the SCA patients (r = 0.39; P = 0.004)
as a whole but not in unsteady state (r = 0.1; P = 0.6).
The correlation betweens e r u ml e p t i nl e v e la n dP. falci-
parum parasitaemia was also not significant among SCA
patients per subgroups and as a whole (r = 0.11 - 0.32;
P >0.05) (Table 5).
Furthermore, modeling of the significant variables
using multivariate regression analysis revealed reticulo-
cyte count (b= 0.1559; P = 0.03) and ESR (b = -0.082;
P = 0.0004) as independent predictor of low leptin level
in the SCA patients (Table 6).
Discussion
Sickle cell anaemia (SCA) remains a major non-infectious
health problem in black populations with Nigeria bearing
the greatest brunt of the disease world wide [1,2,8,9]. The
results of this study show that haemolytic, sickling and
inflammatory episodes coupled with low plasma leptin
level before and after correction for fat mass are wor-
sened in Nigeria patients in the unsteady state of SCA.
The low plasma leptin level observed in our SCA cohort
agrees with findings of Buchowski [37] who reported a
fasting leptin level of 2.26 - 2.36 ng/mL and 5.33 - 7.77
ng/mL in male and female SCD patients relative to 2.49 -
2.59 ng/mL and 15.5 - 28.7 ng/mL in non-SCD male and
female controls respectively. After correction for body fat,
these workers found that leptin levels in the range of 0.21
-0.74 ng/mL/kg were elicited by both sexes of the SCD
patients relative to 0.19 - 1.13 ng/mL/kg by the non-SCD
controls. Although similar patterns of reduction in leptin
level in SCD patients according to sex were obtained, our
observed leptin levels of 2 - 4.1 ng/mL and 2.5 - 12.7 ng/
mL for male and female SCD patients are comparatively
lower. This disparity might be related to difference in
mean ages and sample size of patients used in the two stu-
dies. For instance, the mean ages of male and females SCD
enrolled in the USA study were 15.4 - 30.6 years and 15.4
- 25.6 years for male and female patients respectively.
These ages together with their respective mean weights
were higher than those of this study. Although not deter-
mined, but considering the geographical divide between
t h eU S As t u d ya n dt h ep r e s e n ts t u d y ,d i e t a r yp a t t e r no f
the two enrolled patients may differ and this together with
modifiable lifestyle factors have been found to affect the
level of leptin in circulation in humans independent of
clinical conditions [16,38]. Similar reduction in leptin level
has also been found in patients suffering from fulminant
hepatic failure, hepatitis A, B and C infections, non-alco-
holic steatohepatitis and tuberculosis [19-21,39,40]. To
investigate the cause of low plasma leptin level that was
further reduced significantly during crisis in our patients,
we investigated its relationship with body composition
defined by BMI, fat mass. We found no significant
Table 5 Correlation Analysis on the Relationship between
Leptin Levels, malaria, Inflammation, Heamolytic and
Sickling parameters among the SCD Patients Studied
SCA Patients
Variable Steady (n = 31) Unsteady (n = 24) Total (n = 55)
rP rP r P
Malaria
GMPD. 0.11 0.33 0.35 0.09 0.29 0.1
Haemolytic
PCV 0.28 0.12 0.24 0.32 0.20 0.34
Hb 0.19 0.3 0.22 0.3 0.18 0.38
MCHC 0.15 0.38 0.23 0.27 0.17 0.33
MCH 0.25 0.15 0.24 0.25 0.22 0.29
RBC 0.11 0.56 0.28 0.15 0.14 0.43
Inflammation
ESR -0.55 0.001* -0.72 0.000075 -0.59 0.000016*
Sickling
RC 0.52 0.003* 0.1 0.6 0.39 0.004*
ISC 0.32 0.07 0.13 0.55 0.07 0.6
HbF 0.20 0.25 0.16 0.42 0.18 0.37
Platelet count -0.39 0.03 -0.37 0.08 -0.12 0.72
*Significant P-value (i.e. P < 0.05); r = Correlation coefficient.
Table 6 Multivariate analysis of factors associated with
Low Leptin Levels in the SCD patients
Constant b [t] SE P
5.2
ESR -0.082 4.7 0.017 0.00002*
RC 0.1559 2.3 0.07 0.03*
Platelet count -0.00083 0.4 0.003 0.7
*Significant P-value (i.e. P < 0.05).
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and BMI, suggesting a possible loss of association between
leptin and both adiposity determined by fat mass and BMI
in our HbSS cohort. This possibility is further strength-
ened by our expected finding of positive correlation
between leptin and both BMI and fat mass in the non-
SCD controls, the observation that the pattern of reduc-
tion in plasma leptin levels seen in the two case sub-
groups correlated with pattern of reduction in BMI and fat
mass by gender and the persistence of lower leptin level in
the unsteady SCA sub group after correction for fat mass.
Elsewhere significant positive correlation between lep-
tin and BMI has been found in patients with steatohepa-
titis, chronic hepatitis B and C infection and acute
hepatitis A infections [20,21,40], while van Crevel et al
[19] and Buckowski et al [37] reported a positive corre-
lation between leptin and fat mass in tuberculosis and
sickle cell disease patients. Leptin has been shown in
several studies to elicit positive correlation with acute
phase proteins and inflammatory parameters such as c-
reactive protein, alpha1-antitrypsin, TNF-a, IL-1 and IL-
6 [20] to further show the relevance of this hormone as
an indicator of inflammation. In this study mean ESR
levels of 25.7 mm/hr and 38.4 mm/hr that were above
the normal level (i.e. < 15 m/hr) were found in our
steady and unsteady patients cohorts and this confirm
chronic inflammatory episode aggravated by crisis as a
pathophysiologic component of SCD-HbSS. The higher
mean ESR level observed in the unsteady SCA patients
might be related to the higher parasite rate and parasi-
taemia seen in these patients since Plasmodium falci-
parum evoked acute inflammatory response during
clinical infection [41]. P falciparum infection detected in
the control and steady SCA patients can be said to be
sub-clinical and hence asymptomatic. Our finding seems
to corroborate a study by Kotila et al [42] who reported
an incidence of asymptomatic malaria in SCA patients
from Ibadan south West Nigeria. Malaria is transmitted
perennially but with high intensity during the rainy sea-
son in Nigeria and 98% of the population is at risk of
infections [43]. Furthermore, we found lower asympto-
matic parasitaemia level of 749.6 parasites/uL among
the steady SCA compared to the parasitaemia level of
1078.4 parasites/uL seen in the non-SCD control and
this suggest that high level of parasitaemia may be a
trigger of unsteady state or crisis in SCA patients. It
also indicates a possible lower fever threshold in the
study area being deteriorated by crisis in SCA. The rele-
vance of P. falciparum infection to crisis has previously
been reported in Nigeria and other SCD population set-
tings where malaria is also endemic [1,2,7], while the
observed higher pyrexia rate of 58.3% in our unsteady
SCA patients compared with 25.8% in the steady
patients further supports the possibility of lower fever
threshold that we have suggested. Furthermore, several
studies conducted in Nigeria and other endemic coun-
tries have attributed susceptibility of SCA patients to
clinical and severe malaria to poor complement and
antibody responses coupled with the ability to enhance
parasite sequestration [4,10].
S i n c es y s t e m i cl e p t i ni sm a i n l yf r o mt h ea d i p o s et i s s u e
and leptin level rises with increased inflammatory
response but decreases with reduced adiposity [15-17],
our observed lower plasma leptin level that was exacer-
bated in an unsteady state in the SCA patients studied
represents a balance of these antagonistic events. How-
ever, considering the role of leptin in haematopoiesis and
effects of adipocyte metabolism on leptin production, the
importance of haematological parameters and other adi-
pogenic factors cannot be over-emphasized. The latter
was not investigated in the present study, but studies
have shown that the levels, uptake or sensitivity to insu-
lin, may influence adipocyte leptin production [44]. With
regards to haematological parameters, significantly (P <
0.05) lower level of HbF, a sickling modifier was observed
in our unsteady SCA patients compared to their steady
counterparts. This suggests that patients in the unsteady
state of SCA are poorer in their ability to mount anti-
sickling response via HbF and are thus prone to repeated
and clinical vaso-occlusions instead of the sub-clinical
type, which occurs in a steady state [45].
Under the same shear stress, sickle erythrocytes, owing
to their defective cytoskeleton protein-HbS interactions
are about 1.5 times and 10 times stickier than normal
erythrocyte when oxygenated and during deoxygenation
respectively [46]. HbF is known to modify this interaction
and its abundance in the erythrocyte has been associated
with reduced severity of sickling, vaso-occlusion and clin-
ical manifestations of SCA. This pattern of reduction in
HbF level between the steady and unsteady SCA patients
studied agrees with previous studies by Ahmed et al
[47,48] who reported HbF levels of 6% and 7% in SCD
Nigerian patients without and with priapism in one study
and found 5.4% and 5% of this parameter in SCA patients
without and with opiate dependence in another study.
Therefore, our observed HbF levels of 3.3% and 4.2% in
this study is suggestive of greater risk of sickling and
vaso-oclussions among our cohorts in Lagos. Unlike in
Asia, levels of HbF below 10% are common among Afri-
can SCA patients including Nigeria [45]. Other abnormal
haematological parameters observed in this study such as
elevated level of irreversibly sickled cells, mean leukocyte,
neutrophils, lymphocyte, monocyte, platelets and reticu-
locyte counts as well as decreased erythrocyte count,
PCV, MCH and MCHC are common haematological fea-
tures of SCA as they have also documented from several
studies for SCA patients in Nigeria and other endemic
populations [2,47-49]. Mild to moderate leukocytosis is
Iwalokun et al. BMC Blood Disorders 2011, 11:2
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Page 8 of 11common among SCA patients and this has been attribu-
ted to re-distribution of leukocytes from marginal pool to
a systemic pool of granulocytes, while moderate lympho-
cytosis and monocytosis have been implicated as markers
of inflammation in SCA patients [1,2,4,47,48]. A study by
Wilson et al [50] revealed a positive correlation between
leptin level and WBC count, while Togo et al [51]
showed that leptin associates negatively with haemoglo-
bin. In this study, we did not find significant correlation
between leptin and these haemotological parameters.
This is similar to observations by Caner et al [20] in
hepatitis A patients and Koc et al [52] in healthy term
Japanese infants. Also in this study, the prevalence rates
of 29.2% and 79.2% for MCHC < 31 g/dL and MCH < 25
pg were found in our unsteady SCA patients and higher
than corresponding rates in steady patients, suggesting
higher rate of steady state haemolysis during crisis. Our
results are in consonance with similar studies carried out
in the northern part of the country and Saudi-Arabia
[2,47-49]. It is also important to know that in this study,
the reticulocyte and platelet counts of our unsteady SCA
patients were found to be lower than levels in steady
SCA group. This is contrary to the findings of Ahmed
et al [48] between opiate dependent and non-dependent
SCA patients and between tuberculosis and steady SCA
patients. However, our results align well with report by
the same group of investigators on SCD patients with
and without priapism [47] and the findings of Salawu et
al [10]. These workers attributed crisis-induced decrease
in reticulocyte count to attenuated reticulocyte response
to haemolysis in afflicted patients, while crisis-enhanced
platelet sequestration was considered to be responsible
for their observed platelet reduction. The lowered reticu-
locyte count in our SCA patients may also be due loss
arising from sequestration of the reticulocytes. This is
because recticulocytes of SCA patients are more adhesive
than those of non-SCD control [2,4,5,7,8] and the results
of this study imply that under unsteady state of SCA, the
expression and levels of adhesive molecules factors on
the surface of reticulocytes could be more. This is how-
ever, subject to further investigations.
Elevated platelet has been associated with inflamma-
tion characterized by leukocytosis and elevated ESR in
various disease conditions including SCD [2,4,47-49] as
observed in this study. However, unlike ESR and reticu-
locyte count, platelet failed as independent predictor of
plasma leptin in these patients.
However, this study is limited by the fact that ESR,
which was found to be an independent predictor of
plasma leptin level is a non-specific marker of inflam-
mation [5] and this may limit its prognostic value in
predicting outcome of interventions in SCA patients.
Despite this, ESR has been reported as an important
inflammatory marker together with other specific
markers during steady and unsteady states of SCD
[1,2,10]. Nevertheless, there may be a need to investigate
other more specific inflammatory markers such as b2-
macroglobulin and C-reactive protein in our SCA cohort
in subsequent studies to build more confidence of reli-
ance on the less expensive and easy to implement ESR
assay. Larger sample size is also needed to ascertaining
the fitness of poor reticulocyte response as a determi-
nant of low leptin level in SCA. The fact that the lean
mass data in this study was obtained by calculation is
itself a limitation as it may bias fat mass data of some
patients. However, similar calculation was used for all
the patients as previously carried out by Owa and Ade-
juyigbe [31] in the study area to improve the credibility
of the corresponding anthropometric data obtained in
this study as much as possible. Future studies on the
micronutrient variables such as zinc and vitamin E that
have been associated with growth and immunity in SCD
patients in relation to serum leptin are also advocated.
Conclusion
Nevertheless, within the scope of this study, it can be
concluded that unsteady state of SCA is associated with
much lower plasma leptin level in relation to inflamma-
tion and poor reticulocyte response among Nigerian
patients.
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